Description: Thymosin beta‑4 (TB‑500) is a synthetic peptide derived from the naturally occurring thymosin beta‑4 protein. It is investigated for roles in tissue repair, cell migration, angiogenesis, and anti‑inflammatory signalling in preclinical research models of wound healing, musculoskeletal injury, and fibrosis.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory or regulated clinical research by qualified professionals only. Not for administration to humans or animals outside approved studies. Not a drug, food, or cosmetic; do not misbrand, misuse, or mislabel.